Triglobal Lifesciences (Opc) Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 8 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth 19.87%
- Profit Growth -4075.59%
- Ebitda -442.17%
- Net Worth -510.46%
- Total Assets 43.64%
About Triglobal Lifesciences (Opc)
Triglobal Lifesciences (Opc) Private Limited (TLOPL) is a Company incorporated in India on 24 June 2020 (Four years and eight months 2 days old ). Its registered office is in Solan, Himachal Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vivek Kumar serves as a director at the Company.
Company Details
- Location
Solan, Himachal Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230HP2020OPC007927
- Company No.
007927
- Incorporation Date
24 Jun 2020
- Date of AGM
-
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
What products or services does Triglobal Lifesciences (Opc) Private Limited offer?
Triglobal Lifesciences (Opc) Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibacterial Drugs.
Who are the key members and board of directors at Triglobal Lifesciences (Opc)?
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vivek Kumar  | Director | 24-Jun-2020 | Current |
Financial Performance of Triglobal Lifesciences (Opc).
Triglobal Lifesciences (Opc) Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 19.87% increase. The company also saw a substantial fall in profitability, with a 4075.59% decrease in profit. The company's net worth observed a substantial decline by a decrease of 510.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Triglobal Lifesciences (Opc)?
Unlock access to Triglobal Lifesciences (Opc)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Honor Pharmaceuticals LimitedVivek Kumar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Triglobal Lifesciences (Opc)?
Unlock and access historical data on people associated with Triglobal Lifesciences (Opc), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Triglobal Lifesciences (Opc), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Triglobal Lifesciences (Opc)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.